Chinese Journal of Dermatology ›› 2023, e20210875.doi: 10.35541/cjd.20210875

• Reviews • Previous Articles     Next Articles

Benvitimod for the treatment of dermatoses

Chen Lianghong1,2, Sun Yan1, Wang Jingyu1, Wu Yan1   

  1. 1Department of Dermatology, The First Hospital of China Medical University, Shenyang 110001, China; 2Department of Emergency Medicine, Shengjing Hospital of China Medical University, Shenyang 110801, China
  • Received:2021-12-02 Revised:2022-03-21 Online:2023-01-05 Published:2023-03-20
  • Contact: Wu Yan
  • Supported by:
    National Natural Science Foundation of China(82103758)

Abstract: 【Abstract】 Benvitimod is an aryl hydrocarbon receptor agonist, and has a certain therapeutic effect on some inflammatory dermatoses, such as psoriasis, atopic dermatitis, vitiligo, contact dermatitis and rosacea, by inhibiting the expression of various inflammatory factors via different pathways. This review focuses on research progress in benvitimod for the treatment of dermatoses, with a view to deepening the understanding of its biological effects.

Key words: Receptors, aryl hydrocarbon, Skin disease, Psoriasis, Dermatitis, atopic, Rosacea, Benvitimod